Shabeer Medic Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 06922460 (England and Wales)

Unaudited Financial Statements for the Year Ended 30th June 2025

for

Shabeer Medic Limited

Page

Balance Sheet

1

Notes to the Financial Statements

2

FIXED ASSETS

Tangible assets

4

2,262

2,817

CURRENT ASSETS

Debtors

5

4,275

Cash at bank

2,468

884

6,743

5,159

CREDITORS

Amounts falling due within one year

6

34,262

40,440

NET CURRENT LIABILITIES

(27,519

)

(35,281

)

TOTAL ASSETS LESS CURRENT
LIABILITIES

(25,257

)

(32,464

)

PROVISIONS FOR LIABILITIES

430

535

NET LIABILITIES

(25,687

)

(32,999

)

CAPITAL AND RESERVES

Called up share capital

7

100

Retained earnings

(25,787

)

(33,099

)

SHAREHOLDERS' FUNDS

(25,687

)

(32,999

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11th November 2025 and were signed on its behalf by:

Dr M S Kolakkat - Director

1.	COMPANY INFORMATION

Shabeer Medic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

06922460

Registered office:

The Lexicon

Mount Street

Manchester

M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

25% on cost

Motor vehicles

-

15% on cost

Tangible fixed assets are included at cost less depreciation and impairment. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful life.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern

Despite the fact that the company reports negative reserves at the balance sheet date, at the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

fittings

vehicles

Totals

£

COST

At 1st July 2024

4,094

68,000

72,094

Additions

549

-

549

At 30th June 2025

4,643

68,000

72,643

DEPRECIATION

At 1st July 2024

1,277

68,000

69,277

Charge for year

1,104

-

1,104

At 30th June 2025

2,381

68,000

70,381

NET BOOK VALUE

At 30th June 2025

2,262

-

2,262

At 30th June 2024

2,817

-

2,817

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.6.25

30.6.24

£

Other debtors

4,275

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.6.25

30.6.24

£

Tax

1,891

830

Directors' current accounts

31,670

39,015

Accrued expenses

701

595

34,262

40,440

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.6.25

30.6.24

value:

£

60

Ordinary A

£1

60

40

Ordinary B

£1

40

100

The A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The B Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B Shares rank pari passu in respect of dividend and capital distribution rights.

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30th June 2025 and 30th June 2024:

30.6.25

30.6.24

£

Dr M S Kolakkat and Mrs N M Najeeb

Balance outstanding at start of year

(39,015

)

(36,512

)

Amounts advanced

8,950

4,374

Amounts repaid

(1,605

)

(6,877

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of year

(31,670

)

(39,015

)

The loan is repayable on demand and no interest was charged during the year.

9.	RELATED PARTY DISCLOSURES

Included in Other debtors is a balance of £4,275 due from Revalidaid (UK) Ltd, a company in which Dr Kolakkat has a controlling interest. All transactions were made on an arms length basis.

10.	ULTIMATE CONTROLLING PARTY

The controlling party is Dr M S Kolakkat.